Abstract
This study aimed to compare the efficacy of injectable bone grafts and allograft bone chips in the treatment of benign bone lesions. A total of 34 patients were included, with varying types and locations of lesions. The results showed no significant differences between the two groups in terms of age, gender, lesions type, diagnosis, site of the lesion, and bone leakage. However, the remodelling time was significantly shorter in the injectables group (5+3 months) than in the bone chips group (12+5 months). This study contributes to the understanding of the benefits and limitations of different bone grafting techniques for the treatment of benign bone lesions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
